共 909 条
[61]
Falk JA(2018)Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy Ther Adv Cardiovasc Dis 12 36-F531
[62]
Philip KJ(2020)Angiotensin-neprilysin inhibition in black Americans: data from the PIONEER-HF trial Heart Failure 8 223-F9
[63]
Schwarz ER(2016)AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress Biochem Biophys Res Commun 474 1-1287
[64]
Singh J(1972)Release of a prostaglandin E-like substance from canine kidney by bradykinin: comparison with eledoisin Circ Res 31 493-125
[65]
Lee Y(1972)Differential efect of noradrenaline and renal nerve stimulation on vascular resistance in the dog kidney and the release of a prostaglandin e-like substance Clin Sci 42 116-465
[66]
Kellum JA(2018)Physiological and pathophysiological implications of PGE2 and the PGE2 synthases in the kidney Prostaglandins Other Lipid Mediat 134 176-164
[67]
Kedzierski RM(2022)Mechanisms of podocyte injury and implications for diabetic nephropathy Clin Sci 136 526-117
[68]
Yanagisawa M(2017)Antihypertensive drugs Pharmacol Res 124 F520-F556
[69]
Kuc RE(2013)Roles of Na+/H+ exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis J Pharmacol Sci 122 F1-25
[70]
Carlebur M(2019)Proximal tubule-specific deletion of the NHE3 (Na+/H+ exchanger 3) in the kidney attenuates Ang II (angiotensin II)-induced hypertension in mice Hypertension 74 1279-119